Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathieu Rouanne

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Virchows Archiv : an International Journal of Pathology|February 21, 2015
Clinicopathological characteristics of urothelial bladder cancer in patients less than 40 years oldEva Compérat, Stéphane Larré, Morgan Roupret, et al.
European Urology Oncology|July 2, 2020
European Association of Urology Guidelines on Primary Urethral Carcinoma-2020 UpdateGeorgios Gakis, Harman M Bruins, Richard Cathomas, et al.
European Urology Oncology|August 29, 2024
Final Results of the ANDROCAN Study: Histopathological Characteristics and Biochemical Recurrence at 5 Years of Localized Prostate Cancer According to Preoperative Gonadal StatusYann Neuzillet, Jean-Pierre Raynaud, Jean-François Dreyfus, et al.
European Urology|May 4, 2020
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 GuidelinesJ Alfred Witjes, Harman Max Bruins, Richard Cathomas, et al.
European Journal of Cancer (Oxford, England : 1990)|January 30, 2021
Tumour-infiltrating lymphocyte density is associated with favourable outcome in patients with advanced non-small cell lung cancer treated with immunotherapyIthar Gataa, Laura Mezquita, Caroline Rossoni, et al.
European Urology|July 5, 2016
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder CancerJ Alfred Witjes, Thierry Lebret, Eva M Compérat, et al.
BMC Cancer|July 17, 2016
Osteopontin and thrombospondin-1 play opposite roles in promoting tumor aggressiveness of primary resected non-small cell lung cancerMathieu Rouanne, Julien Adam, Aïcha Goubar, et al.
European Journal of Cancer (Oxford, England : 1990)|November 4, 2022
High serum LDH and liver metastases are the dominant predictors of primary cancer resistance to anti-PD(L)1 immunotherapyLaurent Dercle, Samy Ammari, Elvire Roblin, et al.
European Urology Oncology|December 24, 2019
The Importance of Hospital and Surgeon Volume as Major Determinants of Morbidity and Mortality After Radical Cystectomy for Bladder Cancer: A Systematic Review and Recommendations by the European Association of Urology Muscle-invasive and Metastatic Bladder Cancer Guideline PanelHarman M Bruins, Erik Veskimäe, Virginia Hernández, et al.
Immunity|February 3, 2024
Amphiregulin from regulatory T cells promotes liver fibrosis and insulin resistance in non-alcoholic steatohepatitisThomas M Savage, Katherine T Fortson, Kenia de Los Santos-Alexis, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Virchows Archiv : an International Journal of Pathology|February 21, 2015
Clinicopathological characteristics of urothelial bladder cancer in patients less than 40 years oldEva Compérat, Stéphane Larré, Morgan Roupret, et al.
European Urology Oncology|July 2, 2020
European Association of Urology Guidelines on Primary Urethral Carcinoma-2020 UpdateGeorgios Gakis, Harman M Bruins, Richard Cathomas, et al.
European Urology Oncology|August 29, 2024
Final Results of the ANDROCAN Study: Histopathological Characteristics and Biochemical Recurrence at 5 Years of Localized Prostate Cancer According to Preoperative Gonadal StatusYann Neuzillet, Jean-Pierre Raynaud, Jean-François Dreyfus, et al.
European Urology|May 4, 2020
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 GuidelinesJ Alfred Witjes, Harman Max Bruins, Richard Cathomas, et al.
European Journal of Cancer (Oxford, England : 1990)|January 30, 2021
Tumour-infiltrating lymphocyte density is associated with favourable outcome in patients with advanced non-small cell lung cancer treated with immunotherapyIthar Gataa, Laura Mezquita, Caroline Rossoni, et al.
European Urology|July 5, 2016
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder CancerJ Alfred Witjes, Thierry Lebret, Eva M Compérat, et al.
BMC Cancer|July 17, 2016
Osteopontin and thrombospondin-1 play opposite roles in promoting tumor aggressiveness of primary resected non-small cell lung cancerMathieu Rouanne, Julien Adam, Aïcha Goubar, et al.
European Journal of Cancer (Oxford, England : 1990)|November 4, 2022
High serum LDH and liver metastases are the dominant predictors of primary cancer resistance to anti-PD(L)1 immunotherapyLaurent Dercle, Samy Ammari, Elvire Roblin, et al.
European Urology Oncology|December 24, 2019
The Importance of Hospital and Surgeon Volume as Major Determinants of Morbidity and Mortality After Radical Cystectomy for Bladder Cancer: A Systematic Review and Recommendations by the European Association of Urology Muscle-invasive and Metastatic Bladder Cancer Guideline PanelHarman M Bruins, Erik Veskimäe, Virginia Hernández, et al.
Immunity|February 3, 2024
Amphiregulin from regulatory T cells promotes liver fibrosis and insulin resistance in non-alcoholic steatohepatitisThomas M Savage, Katherine T Fortson, Kenia de Los Santos-Alexis, et al.
Pageof 6